Taylor & Francis Group
Browse
0206 Suppl Fig.docx (67.16 kB)

Supplementary Figure – Niraparib treatment for patients with BRCA-mutated ovarian cancer: review of clinical data and therapeutic context

Download (67.16 kB)
figure
posted on 2022-07-06, 08:38 authored by Taylor & FrancisTaylor & Francis, Antonio Gonzalez-Martın, Ursula A Matulonis, Jacob Korach, Mansoor R Mirza, Kathleen N Moore, Xiaohua Wu, Whitney York, Divya Gupta, Stanislav Lechpammer, Bradley J Monk

Supplemental Figure 1. Kaplan–Meier plots of PFS outcomes in patients with BRCAm in (A) PRIMA, (B) NOVA, and (C) NORA studies of niraparib monotherapy, reproduced from [14, 15, 17].  

Funding

GLAXOSMITHKLINE BIOLOGICALS GSK

Belgian Federal Science Policy Office

Find out more...

History

Usage metrics

    Future Oncology

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC